Integration of metabolomics and transcriptomics to Reveal Potential Biomarkers Associated with Treatment Response of Neoadjuvant Therapy in HER2+Breast Cancer

被引：0
|
作者：
Zhang, Ningning
Huang, Yuxin
Wang, Guanwen
Xiang, Yimei
Jing, Zhouhong
Zeng, Junjie
Yu, Feng
Pan, Xianjun
Zhou, Wenqi
Zeng, Xiaohua
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO3-14-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO3-14-05
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Integration of metabolomics and transcriptomics to reveal potential biomarkers associated with treatment response of neoadjuvant therapy in HER2+breast cancer
    Zhang, N.
    Xiang, Y.
    Jing, Z.
    Yu, F.
    Zeng, J.
    Pan, X.
    Zhou, W.
    Liang, X.
    Yue, Y.
    Zhang, H.
    Deng, Y.
    Deng, S.
    Mo, S.
    Jiang, X.
    Zeng, X.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S249 - S249
  • [2] Metabolomics assisted by transcriptomics analysis to reveal metabolic characteristics and potential biomarkers associated with treatment response of neoadjuvant therapy with TCbHP regimen in HER2+breast cancer
    Zhang, Ningning
    Huang, Yuxin
    Wang, Guanwen
    Xiang, Yimei
    Jing, Zhouhong
    Zeng, Junjie
    Yu, Feng
    Pan, Xianjun
    Zhou, Wenqi
    Zeng, Xiaohua
    [J]. BREAST CANCER RESEARCH, 2024, 26 (01)
  • [3] Potential Biomarkers Associated with Prognosis and Trastuzumab Response in HER2+Breast Cancer
    Castro-Guijarro, Ana Carla
    Sanchez, Angel Matias
    Flamini, Marina Ines
    Vogel, Christoph F. A.
    [J]. CANCERS, 2023, 15 (17)
  • [4] Identification of UGT2B family genes as potential biomarkers of response to neoadjuvant therapy in HER2+breast cancer
    Gil-Torralvo, Ana
    Benavent, Marta
    Dominguez-Cejudo, Maria A.
    Falcon, Alejandro
    Cejuela, Monica
    Vieites, Begona
    Molina-Pinelo, Sonia
    Borrego, Manuel Ruiz
    de la Haba-Rodriguez, Juan
    Queipo, Maria I.
    Bofill, Francisco Javier Salvador
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [5] Integration of transcriptomics, proteomics, and metabolomics data to reveal HER2-associated metabolic heterogeneity in gastric cancer with response to immunotherapy and neoadjuvant chemotherapy
    Yuan, Qihang
    Deng, Dawei
    Pan, Chen
    Ren, Jie
    Wei, Tianfu
    Wu, Zeming
    Zhang, Biao
    Li, Shuang
    Yin, Peiyuan
    Shang, Dong
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [6] Using neoadjuvant therapy response to guide adjuvant therapy in HER2+breast cancer
    Krop, I.
    [J]. BREAST, 2019, 44 : S13 - S13
  • [7] The Pathological Response of Her2+Breast Cancer with Neoadjuvant Chemotherapy and Radiation Therapy
    Chao, M.
    Baker, C.
    Jassal, S.
    Law, M.
    Bevington, E.
    Stoney, D.
    Zantuck, N.
    Chew, G.
    Loh, S. W.
    Hyett, A.
    Guerrieri, M.
    Ng, M.
    Cokelek, M.
    Neoh, D.
    Yong, C.
    Ho, H.
    Tacey, M.
    Joon, D. Lim
    Khor, R.
    Foroudi, F.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E17 - E17
  • [8] Identification of UGT2B15 as a potential biomarker in response to neoadjuvant therapy in HER2+breast cancer
    Gil-Torralvo, Ana
    Benavent, Marta
    Dominguez-Cejudo, Maria A.
    Falcon, Alejandro
    Vieites, Begona
    Molina-Pinela, Sonia
    Ruiz, Manuel
    Montano, Alvaro
    Gonzalez, Rosario
    Martinez, Julia
    de la Haba, Juan
    Rodriguez, Antonio
    Queipo, Maria I.
    Jimenez, Begona
    Salvador-Bofill, Javier
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [9] Loss of HER2 and disease prognosis after neoadjuvant treatment of HER2+breast cancer
    Branco, Francisco P.
    Machado, Duarte
    Silva, Filipa F.
    Andre, Saudade
    Catarino, Ana
    Madureira, Rosa
    Pinto, Joao M.
    Godinho, Joao P.
    Simoes, Pedro D.
    Brito, Margarida
    Casa-Nova, Mafalda
    Moreira, Antbnio R.
    Passos-Coelho, Jose L.
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (09): : 6110 - 6116
  • [10] The impact of antibiotics and proton pump inhibitors in neoadjuvant treatment of HER2+breast cancer
    Martins, J. B.
    Santos, J.
    Mendonca, J. C.
    Barbosa, A. R.
    Lima, B. F.
    Carvalho, C. T.
    Teixeira, A.
    Coutinho, C.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (08) : S1397 - S1398
12345